Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial

被引：0
|
作者：
Peter Schmid
J. Krocker
R. Kreienberg
P. Klare
K. Kittel
H. Sommer
G. Heinrich
T. Steck
W. Lichtenegger
D. Elling
S. Kümmel
机构：
[1] Imperial College London,Department of Medical Oncology, Charing Cross Hospital
[2] Sana Hospital Lichtenberg,Department of Obstetrics and Gynecology
[3] University of Ulm,Department of Obstetrics and Gynecology
[4] Clinic for Gynaecological Oncology,Department of Obstetrics and Gynecology
[5] Ludwig Maximilians University Munich,Department of Obstetrics and Gynecology
[6] Clinic for Gynaecological Oncology,Department of Obstetrics and Gynecology
[7] Hospital Chemnitz,Department of Obstetrics and Gynecology
[8] Charité University Medical Center,undefined
[9] University Hospital Essen,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Docetaxel; Non-pegylated liposomal doxorubicin; Cardiotoxicity; Metastatic breast cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：401 / 406
页数：5
相关论文
共 50 条
  • [21] Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer
    Chang, Amy E.
    Wu, Qian V.
    Jenkins, Isaac C.
    Specht, Jennifer M.
    Gadi, Vijayakrishna K.
    Gralow, Julie R.
    Salazar, Lupe G.
    Kurland, Brenda F.
    Linden, Hannah M.
    CLINICAL BREAST CANCER, 2018, 18 (01) : E143 - E149
  • [22] Non-pegylated liposomal doxorubicin use in the treatment of bilateral breast cancer
    Nowaczyk, Monika
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 : A40 - A42
  • [23] Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE
    de la Fouchardiere, C.
    Largillier, R.
    Goubely, Y.
    Hardy-Bessard, A. -C.
    Slama, B.
    Cretin, J.
    Orfeuvre, H.
    Paraiso, D.
    Bachelot, T.
    Pujade-Lauraine, E.
    ANNALS OF ONCOLOGY, 2009, 20 (12) : 1959 - 1963
  • [24] Comment on Pegylated Liposomal Doxorubicin Plus Docetaxel in Metastatic Breast Cancer
    Smith, Thomas J.
    Hillner, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : E128 - E128
  • [25] Non-pegylated liposomal doxorubicin in metastatic breast cancer (MBC) - Results from an Austrian post marketing surveillance programme
    Steger, G. G.
    Mlineritsch, B.
    Bartsch, R.
    Pluschnig, U.
    Petru, E.
    Peintinger, F.
    Sevelda, P.
    Greil, R.
    ONKOLOGIE, 2010, 33 : 55 - 55
  • [26] Bevacizumab in combination with docetaxel plus trastuzumab ± non-pegylated liposomal doxorubicin: Final results of ABCSG-32, a prospective, randomized phase II-study
    Steger, Guenther G.
    Greil, Richard
    Hubalek, Michael
    Fridrik, Michael A.
    Singer, Christian F.
    Bartsch, Rupert
    Balic, Marija
    Dubsky, Peter
    Egle, Daniel
    Gampenrieder, Simon P.
    Pfeiler, Georg
    Mayr, David
    Czech, Theresa
    Rinnerthaler, Gabriel
    Exner, Ruth
    Petzer, Andreas L.
    Sevelda, Paul
    Lang, Alois
    Rudas, Margaretha
    Krause, Barbara
    Seifert, Michael
    Frantal, Sophie
    Zielinski, Christoph C.
    Gnant, Michael
    CANCER RESEARCH, 2015, 75
  • [27] Non-pegylated liposomal doxorubicin in metastatic breast cancer patients: A valuable therapeutic option requiring caution
    Bernardi, Daniele
    Errante, Domenico
    Stefani, Micaela
    Salvagno, Luigi
    BREAST, 2010, 19 (06): : 549 - 550
  • [28] Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer
    Fasano, Julie
    Hershman, Dawn
    Novik, Yelena
    Levinson, Benjamin
    Blozie, Kim
    Tiersten, Amy D.
    BREAST CARE, 2010, 5 (01) : 17 - 21
  • [29] Phase II study of pegylated liposomal doxorubicin (Caelyx®) and docetaxel as first-line treatment in metastatic breast cancer
    Alexopoulos, A
    Karamouzis, MV
    Stavrinides, H
    Ardavanis, A
    Kandilis, K
    Stavrakakis, J
    Georganta, C
    Rigatos, G
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 891 - 895
  • [30] Pegylated or non-pegylated liposomal doxorubicin in the management of advanced breast cancer: a meta-analysis
    Huang, Man
    Chen, Zhi-Lan
    Fu, Jun
    Wang, Xia-Rong
    Gao, Jian-Qing
    Xia, Zheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 525 - 534
12345